What is the ticker symbol for Solid Biosciences?

Solid Biosciences trades under the ticker SLDB on NASDAQ.

What sector does Solid Biosciences operate in?

Solid Biosciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze SLDB in a portfolio?

PortView shows SLDB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Solid Biosciences (SLDB) Stock Analysis

NASDAQHealthcareBiotechnology

$9.82-0.61%

1-year price historyRange $3.93 – $11.15

52-week range$9.82

$3.79$11.45

What Solid Biosciences does

Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, which represents a next-generation gene transfer therapy intended for DMD. Beyond specific drug candidates, Solid Biosciences is actively developing innovative platform technologies, such as "dual gene expression," a technique that allows for multiple therapeutic genes to be bundled into a single viral vector, and researching new capsid designs. The company maintains a strategic alliance through a collaboration and license agreement with Ultragenyx Pharmaceutical Inc., focusing on the joint development and market introduction of novel gene therapies for Duchenne Muscular Dystrophy. Founded in 2013, Solid Biosciences Inc. conducts its operations from its headquarters in Cambridge, Massachusetts.

Key metrics

Market cap

$966.78M

P/E (TTM)

-5.22

EPS (TTM)

$-1.88

Beta

2.42

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$9.22

200-day avg

$7.22

52-week high

$11.45

52-week low

$3.79

CEO

Alexander G. Cumbo

ETFs linked to SLDB

Broad-market and Healthcare sector ETFs an investor holding Solid Biosciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how SLDB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze SLDB in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Solid Biosciences?: Solid Biosciences trades under the ticker SLDB on NASDAQ.
Which exchange is SLDB listed on?: SLDB is listed on NASDAQ.
What sector does Solid Biosciences operate in?: Solid Biosciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze SLDB in a portfolio?: PortView shows SLDB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.